Covered recipient · General Payments record
SAMIR S BANGALORE
Allopathic & Osteopathic Physicians Psychiatry & Neurology Epilepsy
General Payments · PY2018–2024
$130,361.29
- Reported across 565 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Honoraria | $10,450.00 | 4 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,000.00 | 3 |
| Consulting Fee | $3,360.00 | 1 |
| Food and Beverage | $2,705.83 | 58 |
| Travel and Lodging | $2,500.14 | 7 |
| Education | $58.50 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $13,975.60 | 30 |
| SK Life Science, Inc. | $10,837.18 | 12 |
| LivaNova USA, Inc. | $312.27 | 2 |
| Neurelis, Inc. | $210.14 | 9 |
| JAZZ PHARMACEUTICALS INC. | $177.61 | 3 |
| Marinus Pharmaceuticals, Inc. | $147.61 | 1 |
| Neurocrine BioSciences, Inc. | $89.93 | 3 |
| Genentech USA, Inc. | $65.33 | 2 |
| Teva Pharmaceuticals USA, Inc. | $49.87 | 3 |
| CATALYST PHARMACEUTICALS, INC. | $34.54 | 2 |
| ABBVIE INC. | $33.48 | 1 |
| ARGENX US, INC. | $27.61 | 1 |
| NEUROPACE, INC. | $26.87 | 1 |
| Amneal Pharmaceuticals LLC | $25.61 | 1 |
| EISAI INC. | $22.84 | 1 |
| Medtronic, Inc. | $20.94 | 1 |
| Alexion Pharmaceuticals, Inc. | $17.04 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (74)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.